| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2973240 | The Journal of Heart and Lung Transplantation | 2006 | 4 Pages |
Abstract
Soluble CD30 before lung transplantation is significantly associated with an increased risk of BOS after transplantation.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Anja Marcelien MD, Ed A. MD, PhD, Walter G.J. (FRCS), Diana A. MD, Henny G. PhD,